Sofosbuvir/simeprevir versus sofosbuvir/ribavirin regimen in Egyptian patients with hepatitis C virus

Conclusion A 12-week course of sofosbuvir/simeprevir showed a higher response rate than 24 weeks of sofosbuvir/ribavirin among patients with HCV-related Child A cirrhosis.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research